Interferon- Therapy in Multiple Sclerosis: Evidence for a Clinically Relevant Dose Response

By Goodin D.S.  

Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. : 1693-1703

Adis International

Access to resources Recommend Favorite

DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy

By  

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-12 ,pp. : 289-304

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Resistance to Imatinib in CML Patients: A Paradigm for the Advantages and Pitfalls of Molecularly Targeted Therapy

By  

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-12 ,pp. : 645-657

Bentham Science Publishers

Access to resources Recommend Favorite

Side Effects of Interferon-α Therapy

By Sleijfer Stefan   Bannink Marjolein   Gool Arthur   Kruit Wim   Stoter Gerrit  

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 423-431

Springer Publishing Company

Access to resources Recommend Favorite

Managing the Adverse Effects of Interferon- Therapy in Multiple Sclerosis

By Bayas A.   Rieckmann P.  

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 149-159

Adis International

Access to resources Recommend Favorite